Compare CFBK & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFBK | INGN |
|---|---|---|
| Founded | 1892 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.4M | 168.6M |
| IPO Year | 2005 | 2013 |
| Metric | CFBK | INGN |
|---|---|---|
| Price | $27.80 | $6.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $29.00 | $11.00 |
| AVG Volume (30 Days) | 41.7K | ★ 233.0K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | 30.58 | ★ 43.42 |
| EPS | ★ 2.69 | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | $32.28 | $7.92 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | $10.28 | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $19.22 | $5.34 |
| 52 Week High | $34.34 | $9.13 |
| Indicator | CFBK | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 48.02 |
| Support Level | $23.49 | $5.95 |
| Resistance Level | $29.95 | $6.19 |
| Average True Range (ATR) | 0.69 | 0.24 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 33.75 | 19.70 |
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.